Assets of Stada's two subsidiaries in Russia, NizhpharmandMakiz-Pharma, have been consolidated and re-named Stada CIS, but the two companies' products will continue to be marketed under their previous brand names.
Dmitriy Yefimov, Stada's vice-president for Russia and the CIS and Nizhpharm's director general, will become the head of Stada CIS's...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?